Madison Wealth Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Buy
3,759
+11
+0.3% +$1.13K 0.04% 210
2026
Q2
$371K Buy
3,748
+11
+0.3% +$991 0.05% 187
2026
Q1
$324K Buy
+3,737
New +$327K 0.05% 154

Other funds holding IHE

Madison Wealth Partners's IHE Position: Q3 2026 in Review

Madison Wealth Partners increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.29% in Q3 2026, buying an estimated $1.13K and bringing the position to 3,759 shares worth $378K. The position accounts for 0.04% of the portfolio, ranked #210.

Madison Wealth Partners first reported a position in IHE in Q1 2026 and has held it in 3 quarters since. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Madison Wealth Partners held 3,759 shares of iShares US Pharmaceuticals ETF worth $378K as of Q3 2026.
  • Madison Wealth Partners bought 11 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $1.13K.
  • iShares US Pharmaceuticals ETF made up 0.04% of Madison Wealth Partners's portfolio in Q3 2026, its #210 holding.
  • Madison Wealth Partners first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and has held it in 3 quarters since.
  • 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Madison Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.